There should be a change in SOP parameters for evaluating FDCs: Dr RK Sanghavi
A sub-committee of DTAB has asked manufacturers of FDCs which were considered irrational by Prof Kokate Committee to present their…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
fixed dose combinations
Industry experts disagree with NPPA’s remark on FDCs
Experts say it is beyond the jurisdiction of NPPA
Delhi HC questions govt over urgency to ban over 300 FDC drugs
Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and…